Correlates of insulin injection omission

Mark Peyrot, Richard R Rubin, Davida F Kruger, Luther B Travis, Mark Peyrot, Richard R Rubin, Davida F Kruger, Luther B Travis

Abstract

Objective: The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections.

Research design and methods: Data were obtained through an Internet survey of 502 U.S. adults self-identified as taking insulin by injection to treat type 1 or type 2 diabetes. Multiple regression analysis assessed independent associations of various demographic, disease, and injection-specific factors with insulin omission.

Results: Intentional insulin omission was reported by more than half of respondents; regular omission was reported by 20%. Significant independent risk factors for insulin omission were younger age, lower income and higher education, type 2 diabetes, not following a healthy diet, taking more daily injections, interference of injections with daily activities, and injection pain and embarrassment. Risk factors differed between type 1 and type 2 diabetic patients, with diet nonadherence more prominent in type 1 diabetes and age, education, income, pain, and embarrassment more prominent in type 2 diabetes.

Conclusions: Whereas most patients did not report regular intentional omission of insulin injections, a substantial number did. Our findings suggest that it is important to identify patients who intentionally omit insulin and be aware of the potential risk factors identified here. For patients who report injection-related problems (interference with daily activities, injection pain, and embarrassment), providers should consider recommending strategies and tools for addressing these problems to increase adherence to prescribed insulin regimens. This could improve clinical outcomes.

References

    1. Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey. Age-Adjusted Percentage of Adults with Diabetes using Diabetes Medication by Type of Medication, United States, 1997–2003 Data computed by the personnel of the Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC: Available online at 2008
    1. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193– 203
    1. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005; 28: 78– 83
    1. Morris AD, Boyle DIR, McMahon D, MacDonald TM, Newton RWfor the DRTS/MEMO Collaboration. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997; 350: 1505– 1510
    1. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006; 28: 1712– 1725
    1. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005; 118( Suppl. 3): 27S– 34S
    1. Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost- related medication underuse. Health Econ Policy Law 2008; 3: 51– 67
    1. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20: 1512– 1517
    1. Gonzalez J, Peyrot M, McCarl A, Collins E, Serpa L, Mimiaga M, Safren S. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008; 31: 2398– 2403
    1. Olmsted MP, Colton PA, Daneman D, Rydall AC, Rodin GM. Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care 2008; 31: 1978– 1982
    1. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the Insulin Treatment Satisfaction Questionnaire. Clin Ther 2004; 26: 565– 578
    1. Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care 2005; 28: 53– 58
    1. Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care 2000; 23: 765– 769
    1. Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001; 51: 665– 672
    1. Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes 2007; 5: 69– 75
    1. Martinez L, Consoli SM, Monnier L, Simon D, Wong O, Yomtov B, Gueron B, Benmedjahed K, Guillemin I, Arnould B. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring, and initial validation of a new self-administered questionnaire. Health Qual Life Outcomes 2007; 5: 53– 63
    1. Peyrot M, Skovlund SE, Landgraf R. Epidemiology and correlates of weight worry in the multi-national Diabetes Attitudes, Wishes and Needs (DAWN) Study. Curr Med Res Opin 2009; 25: 1985– 1993
    1. Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ 2009; 35: 1014– 1022
    1. Link BG, Phelan JC, Miech R, Westin EL. The resources that matter: fundamental social causes of health disparities and the challenge of intelligence. J Health Soc Behav 2008; 49: 72– 91
    1. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154– 2160
    1. The Diabetes Prevention Program Research Group. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care 2005; 28: 830– 837
    1. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetes. Diabetes Care 1999; 22: 448– 452
    1. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, Blais MA, Meigs JB, Grant RW. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30: 2222– 2227
    1. Peyrot M, Rubin RR. Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care 2007; 30: 2433– 2440

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren